BioSpace News Archive

Pharm Country

Pfizer’s Cancer Portfolio Expected to Rake in $8.3 Billion in 2019

Pfizer is a big company with a diverse portfolio, but it hasn’t really been noted for its presence in the oncology market. But now, Pfizer offers 17 drugs to treat cancer, with four approved in the U.S. in 2017.

January 28, 2019
·
3 min read
·
Mark Terry
Career Advice

Job Seekers Beware: Watch for These Red Flags in a Job Interview That Predict a Potentially Toxic Employer

Not only are interviewers tasked with evaluating whether or not you’re a good fit for their organization and the role, but you also should take every opportunity you can to evaluate if the position, company, and team is a good match for your own career goals and needs.

January 28, 2019
·
4 min read
·
Editorial Staff
Policy

Trial for Former Insys Therapeutics Founder John Kapoor and Other Executives Set to Begin Today

The former executives have been charged with initiating kickback schemes, as well as falsifying data, to increase sales of its powerful opioid Subsys.

January 28, 2019
·
3 min read
·
Alex Keown
Deals

Biotechs Scramble to Get IPOs Moving Now That Government Is Open

Numerous biotech companies had filed for initial public offerings (IPOs) during the five-week government shutdown, but were unlikely to actually be able to be listed until the U.S. Securities and Exchange Commission (SEC) had a chance to review their filings.

January 28, 2019
·
3 min read
·
Mark Terry
Business

Purdue Pharma Forges Agreement With Alivio Therapeutics to Advance a Non-Opioid Pain Therapy

While Purdue battles numerous lawsuits over its alleged role in the opioid crisis, the Connecticut-based company has made inroads into developing non-opioid pain treatments.

January 28, 2019
·
3 min read
·
Alex Keown
Drug Development

Alexion’s Ultra-Rare Kidney Disease Drug Passes Phase III With Flying Colors

Boston-based Alexion’s Ultomiris (ravulizumab-cwvz) hit its primary objective in its Phase III study of complement inhibitor-naïve patients with atypical hemolytic uremic syndrome (aHUS).

January 28, 2019
·
3 min read
·
Mark Terry
Drug Development

A Link Between Gum Disease and Alzheimer’s?

Sometimes it seems like just about every disease, including heart attacks, have been linked to gum disease. And sometimes it seems like just about everything from aluminum pots to herpes virus has been linked to Alzheimer’s.

January 28, 2019
·
3 min read
·
Mark Terry
Deals

GSK Investors Await Results From CEO Emma Walmsley’s Maneuvers

Since taking over the helm of GlaxoSmithKline in 2017, Chief Executive Officer Emma Walmsley has made some significant moves to redefine the company as one focused on the development of pharmaceuticals.

January 28, 2019
·
3 min read
·
Alex Keown
Business

FDA Gives Greenlight to Janssen and AbbVie’s Imbruvica for the 10th Time

The approval of the combination marks a first for the U.S. market. The combination of AbbVie and Janssen’s Imbruvica with Roche’s Gazyva is the first chemotherapy-free, anti-CD20 combination to treat CLL and SLL patients who have not yet started therapy, AbbVie said this morning.

January 28, 2019
·
2 min read
·
Alex Keown
Drug Development

Researchers Develop Virus-Free and Oncogene-Free Induced Pluripotent Stem Cell Reprogramming

Researchers with Iowa-based Cellular Engineering Technologies, the John Paul II Medical Research Institute and the University of Iowa published research in late 2018 describing a safer and ethical method of creating pluripotent stem cells from cord blood and peripheral blood.

January 28, 2019
·
3 min read
·
Mark Terry